Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2074
Experience on the Use of Obinutuzumab off Label in Patients with Refractory Idiopathic Inflammatory Myopathy
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 2315
Exploring Antibodies in Psoriatic Arthritis: A Novel Autoimmune Biomarker Discovered
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2162
Exploring Barriers to Rheumatoid Arthritis Treatment Changes: Insights into Patient Concerns
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2100
Exploring the Association Between Basketball Participation and Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Osteoarthritis – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1918
Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 1847
Expression Levels of the ATP-Gated Ion Channel P2RX7 Do Not Predict T Cell Sensitivity to Extracellular ATP and NAD
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 2152
Factors Associated with Health-related Quality of Life in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – a Cross Sectional Analysis from the SAPHO-CNO Study
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2324
Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients with and Without First-degree Relatives with Psoriatic Disease
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2329
Feasibility of a Streamlined Approach for Psoriatic Arthritis Screening and Symptom Assessment
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2228
Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2447
Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 1997
Features of interleukin-1 and interleukin-6 Inhibitor (IL-1i/IL-6i) Related Severe Delayed Adverse Reactions in Subjects with or Without Reaction-risk Associated HLA-DRB1*15
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2165
Fertility Concerns in Adolescents and Young Adults Receiving Gonadotoxic Medications for Rheumatic Disease
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2298
Fibroblast-driven Ttek Activation May Drive Acinar Cell Dysfunction in Sjögren’s Disease, Prior to Lymphocytic Infiltration